8-K - Xeris Biopharma Holdings, Inc. (0001867096) (Filer)
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Xeris Biopharma Holdings filed an 8-K with the SEC on Nov 2 (a notice of a material company event).
Directly affected
- XERS Xeris Biopharma Holdings+17.7% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Xeris Biopharma Holdings belongs to, so it often moves with news about it.
- LLY Eli Lilly and+22.4% 30d
Eli Lilly and is a peer of Xeris Biopharma Holdings in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson-1.7% 30d
Johnson & Johnson is a peer of Xeris Biopharma Holdings in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+7.8% 30d
AbbVie is a peer of Xeris Biopharma Holdings in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+1.9% 18d
Merck is a peer of Xeris Biopharma Holdings in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories+7.0% 30d
Abbott Laboratories is a peer of Xeris Biopharma Holdings in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| XERS | -4.67% | -0.70% | base | -5.32% | -3.27% | -2.33% | after close |
| XLV | -3.03% | -2.77% | base | +0.05% | -0.48% | +2.59% | after close |
| LLY | -9.71% | -8.92% | base | +0.15% | -0.54% | +0.07% | after close |
| JNJ | -2.53% | -0.72% | base | -0.58% | -2.59% | +1.13% | after close |
| ABBV | -2.71% | -2.90% | base | -1.96% | -3.03% | -0.45% | after close |
| MRK | -5.94% | -5.65% | base | -0.39% | -3.26% | +0.55% | after close |
| ABT | -1.26% | -3.36% | base | +3.81% | +2.97% | +9.08% | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-02 AccNo: 0001867096-26-000095 Size: 232 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation F…
Source: sec-edgar
Price since this story was published: Xeris Biopharma Holdings (XERS)
| Company | When | Move | Status |
|---|---|---|---|
| AbbVie (ABBV) | that day | -1.96% | final price |
| AbbVie (ABBV) | the next day | -3.03% | final price |
| AbbVie (ABBV) | two days later | -0.45% | final price |
| AbbVie (ABBV) | three days earlier | -2.90% | final price |
| AbbVie (ABBV) | five days earlier | -2.71% | final price |
| Abbott Laboratories (ABT) | that day | +3.81% | final price |
| Abbott Laboratories (ABT) | the next day | +2.97% | final price |
| Abbott Laboratories (ABT) | two days later | +9.08% | final price |
| Abbott Laboratories (ABT) | three days earlier | -3.36% | final price |
| Abbott Laboratories (ABT) | five days earlier | -1.26% | final price |
| Johnson & Johnson (JNJ) | that day | -0.58% | final price |
| Johnson & Johnson (JNJ) | the next day | -2.59% | final price |
| Johnson & Johnson (JNJ) | two days later | +1.13% | final price |
| Johnson & Johnson (JNJ) | three days earlier | -0.72% | final price |
| Johnson & Johnson (JNJ) | five days earlier | -2.53% | final price |
| Eli Lilly (LLY) | that day | +0.15% | final price |
| Eli Lilly (LLY) | the next day | -0.54% | final price |
| Eli Lilly (LLY) | two days later | +0.07% | final price |
| Eli Lilly (LLY) | three days earlier | -8.92% | final price |
| Eli Lilly (LLY) | five days earlier | -9.71% | final price |
| Merck (MRK) | that day | -0.39% | final price |
| Merck (MRK) | the next day | -3.26% | final price |
| Merck (MRK) | two days later | +0.55% | final price |
| Merck (MRK) | three days earlier | -5.65% | final price |
| Merck (MRK) | five days earlier | -5.94% | final price |
| Xeris Biopharma Holdings (XERS) | that day | -5.32% | final price |
| Xeris Biopharma Holdings (XERS) | the next day | -3.27% | final price |
| Xeris Biopharma Holdings (XERS) | two days later | -2.33% | final price |
| Xeris Biopharma Holdings (XERS) | three days earlier | -0.70% | final price |
| Xeris Biopharma Holdings (XERS) | five days earlier | -4.67% | final price |
| Select Sector Spdr Tr (XLV) | that day | +0.05% | final price |
| Select Sector Spdr Tr (XLV) | the next day | -0.48% | final price |
| Select Sector Spdr Tr (XLV) | two days later | +2.59% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | -2.77% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -3.03% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 33 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 38 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 55 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 49 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 75 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Pete Sessions sold Abbott Laboratories (ABT) (held by a spouse), worth $50,001 - $100,000 on 2 Oct 2026. That is 31 days before publication. Filed 27 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Abbott Laboratories (ABT), worth $1,001 - $15,000 on 18 Sep 2026. That is 45 days before publication. Filed 12 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Abbott Laboratories (ABT), worth $1,001 - $15,000 on 17 Sep 2026. That is 46 days before publication. Filed 30 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - Xeris Biopharma Holdings, Inc. (0001867096) (Filer)”
Companies tied to this story
- XERS Xeris Biopharma Holdings
Xeris Biopharma Holdings (XERS) is linked, with no stored direction, high confidence in the 2 Nov 2026 story “8-K - Xeris Biopharma Holdings, Inc. (0001867096) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> XERS
- XLV Select Sector Spdr Tr
In “8-K - Xeris Biopharma Holdings, Inc. (0001867096) (Filer),” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR holds the health sector that Xeris Biopharma Holdings belongs to, so it often moves with news about it
- LLY Eli Lilly
In “8-K - Xeris Biopharma Holdings, Inc. (0001867096) (Filer),” Eli Lilly (LLY) is linked, with no stored direction, medium confidence. Reason on file: Eli Lilly and is a peer of Xeris Biopharma Holdings in pharmaceutical preparations; rivals often move on the same news
- JNJ Johnson & Johnson
Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “8-K - Xeris Biopharma Holdings, Inc. (0001867096) (Filer).” Reason on file: Johnson & Johnson is a peer of Xeris Biopharma Holdings in pharmaceutical preparations; rivals often move on the same news
- ABBV AbbVie
For “8-K - Xeris Biopharma Holdings, Inc. (0001867096) (Filer),” AbbVie (ABBV) is linked, with no stored direction, medium confidence. Reason on file: AbbVie is a peer of Xeris Biopharma Holdings in pharmaceutical preparations; rivals often move on the same news
- MRK Merck
For “8-K - Xeris Biopharma Holdings, Inc. (0001867096) (Filer),” Merck (MRK) is linked, with no stored direction, medium confidence. Reason on file: Merck is a peer of Xeris Biopharma Holdings in pharmaceutical preparations; rivals often move on the same news
- ABT Abbott Laboratories
For “8-K - Xeris Biopharma Holdings, Inc. (0001867096) (Filer),” Abbott Laboratories (ABT) is linked, with no stored direction, medium confidence. Reason on file: Abbott Laboratories is a peer of Xeris Biopharma Holdings in pharmaceutical preparations; rivals often move on the same news
How “8-K - Xeris Biopharma Holdings, Inc. (0001867096) (Filer)” reaches Xeris Biopharma Holdings (XERS)
On 2 Nov 2026, “8-K - Xeris Biopharma Holdings, Inc. (0001867096) (Filer)” is the story that connects Xeris Biopharma Holdings (XERS) to this story.
For Xeris Biopharma Holdings (XERS), the reason on file says SEC 8-K filing -> direct issuer disclosure -> XERS
Also listed, Select Sector Spdr Tr (XLV): Health Care Select Sector SPDR holds the health sector that Xeris Biopharma Holdings belongs to, so it often moves with news about it
Price levels for Xeris Biopharma Holdings (XERS)
LLY traded between 1131.55 and 1447.86 across 20 sessions. The latest close on file is 1409.39. XERS traded between 9.04 and 11.41 across 20 sessions. The latest close on file is 10.36.
What the saved facts support for Xeris Biopharma Holdings (XERS)
46 out of 100
“8-K - Xeris Biopharma Holdings, Inc. (0001867096) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.